Eloxx Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Eloxx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$7.5M, a 207% decline year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.81M, a 82.6% decline from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $50.8M.
  • Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$3.44M, a 107% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.81M -$42M -82.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $50.8M +$54.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$3.44M -$50.2M -107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $46.8M -$9.38M -16.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 $56.2M +$18.2M +48% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $38M +$28.2M +290% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 $9.74M +$5.85M +151% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $3.88M -$4.85M -55.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $8.73M +$4.7M +116% Jul 1, 2013 Jun 30, 2014 10-K 2014-09-29
2013 $4.03M +$805K +24.9% Jul 1, 2012 Jun 30, 2013 10-K 2014-09-29
2012 $3.23M +$1.57M +94.3% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-29
2011 $1.66M -$10.5M -86.3% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-11
2010 $12.1M Jul 1, 2009 Jun 30, 2010 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.